or
Sign in to turn on 1-Click ordering.
More Buying Choices
Have one to sell? Sell yours here
Cardiac Drug Development Guide (Methods in Pharmacology and Toxicology)
 
 
Tell the Publisher!
I'd like to read this book on Kindle

Don't have a Kindle? Get your Kindle here, or download a FREE Kindle Reading App.

Cardiac Drug Development Guide (Methods in Pharmacology and Toxicology) [Hardcover]

Michael K. Pugsley (Editor)

Price: $150.00 & this item ships for FREE with Super Saver Shipping. Details
  Special Offers Available
o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o
Usually ships within 1 to 3 weeks.
Ships from and sold by Amazon.com. Gift-wrap available.
Textbook Student FREE Two-Day Shipping for Students. Learn more


Book Description

1588290972 978-1588290977 July 30, 2003 1
A comprehensive survey of the latest therapeutic drug discoveries in cardiac and cardiovascular medicine and of the most recent breakthroughs in molecular cardiology. The authors describe the most advanced procedures in cardiac pharmacology today, including in vivo and in vitro whole animal studies, the electrophysiological methods used to study in pacemaker cells, and the application of biochemical principles and technologies to novel therapeutic agents. Also discussed are the methods used to express the ion channels involved in cardiovascular pharmacology, adenoviral vector delivery for cardiovascular gene therapy, pharmacometrics in cardiovascular drug development, gender differences in heart failure, and angiogenesis therapies for coronary heart disease.

Special Offers and Product Promotions

  • Buy $50 in qualifying physical textbooks, get $5 in Amazon MP3 Credit. Here's how (restrictions apply)

Editorial Reviews

Review

"This book provides a comprehensive overview of many advanced procedures in cardiac pharmacology that should be useful for graduate students and academic scientists as well as researchers in the pharmaceutical and biotechnology drug industries. This is an excellent book for researchers with an interest in cardiac pharmacology. Chapters address a broad spectrum of therapeutic areas and discuss appropriate molecular, biochemical, and electrophysiological in vitro as well as in vivo approaches used in the investigation of cardiovascular pharmacology. Moreover, the book addresses current clinical therapeutic trends in cardiovascular medicine."-Doody's Health Sciences Book Review Journal

"The scope of material covered is comprehensive, providing eclectic coverage of some very topical issues in cardiac biology and cardiac medicine...most of the chapters will be of interest to a much wider audience than pharmacologists...a worthwhile purchase." - Journal of Pharmacological and Toxicological Methods

"This textbook is a comprehensive look into the latest in cardiovascular drug developments and novel therapeutic agents. It covers a broad spectrum of therapeutic areas including ionic channels, adenoviral vector delivery for cardiovascular gene therapy, pharmacometrics, and gender differences in heart failure and angiogenesis therapy in coronary heart disease. It would be useful for clinical researchers and pharmacologists in cardiac drug development. Research scientists, graduate students and pharmacologists involved in both the pharmaceutical and biotechnological drug industries would benefit from this book." - E-STREAMS

From the Back Cover

The revolution in molecular medicine makes it imperative to integrate the classical and molecular approaches to drug development for the treatment of heart disease, the number one killer in North America and Europe. In the Cardiac Drug Development Guide, basic medical researchers, clinicians, and pharmacologists join forces to comprehensively survey the most recent breakthroughs in molecular cardiology and review the latest drug discoveries in cardiac and cardiovascular medicine. Topics range from novel molecular targets for cardiac drug development, to functional endpoints for evaluating cardiac drug activity, to clinical aspects of cardiovascular therapeutics. The authors describe the most advanced procedures in cardiovascular pharmacology, including in vivo and in vitro whole animal studies, the electrophysiological methods used to study pacemaker cells, and the application of biochemical principles and technologies to novel therapeutic agents. Also discussed are the methods used to express the ion channels involved in cardiovascular pharmacology, adenoviral vector delivery for cardiovascular gene therapy, pharmacometrics in cardiovascular drug development, gender differences in heart failure, and angiogenesis therapies for coronary heart disease. Each chapter concisely illustrates the concepts described and includes comprehensive background information, detailed figures and tables, and an up-to-date list of the most important references. Comprehensive and easy-to-understand, the Cardiac Drug Development Guide offers pharmacologists, cardiologists, and physiologists not only a gold-standard survey of the many different methods being used to develop new heart drugs, but also details powerful new ways in which cardiovascular disease is targeted, from the whole organ to the genetic level.

Product Details


Customer Reviews


There are no customer reviews yet.
Video reviews
Video reviews
Amazon now allows customers to upload product video reviews. Use a webcam or video camera to record and upload reviews to Amazon.



Inside This Book (learn more)
First Sentence:
Statistics from the American Heart Association show that the total number of arrhythmia-related mortalities is approx 500,000 of an estimated 2,000,000 US deaths per year, or nearly one-quarter of all cardiovascular-related deaths (1). Read the first page
Key Phrases - Statistically Improbable Phrases (SIPs): (learn more)
delayed cardiac protection, ischemic arrhythmogenesis, specific bradycardic agents, cardiovascular drug development, delayed cardioprotection, angiogenesis trials, heart failure process, ischemic arrhythmias, arrhythmia severity, inhibitor cariporide, delayed protection, mouse ventricular myocytes, cardioprotection induced, mouse myocardium, preconditioning stimulus, pacemaker channels, safety pharmacology studies, human atrial fibrillation, human ventricular myocytes, pacing stimulus, cardiac ion channels, inherited cardiac arrhythmia, mammalian myocardium, antiarrhythmic effects, lethal ventricular arrhythmias
Key Phrases - Capitalized Phrases (CAPs): (learn more)
Cell Cardiol, Basic Res, Cardiac Drug Development Guide Edited, Humana Press Inc, New York, Heart Circ, United States, Clin Invest, American Heart Association, Biochemical Mediators of Ventricular Arrhythmias, Pflugers Arch, Free Rad, Role of Cardiac Pacemaker Currents, Sodium-Hydrogen Exchange System, Elsevier Science, Platelet Glycoprotein Antagonists, Redox Sign, Naunyn Schmiedebergs Arch, Trends Cardiovasc, Van Wagoner, Agents Actions, Cardiac Adenoviral-Mediated Gene Therapy, Life Sci, Monte Carlo, Boca Raton
New!
Books on Related Topics | Concordance | Text Stats
Browse Sample Pages:
Front Cover | Table of Contents | First Pages | Index | Back Cover | Surprise Me!
Search Inside This Book:




Tag this product

 (What's this?)
Think of a tag as a keyword or label you consider is strongly related to this product.
Tags will help all customers organize and find favorite items.
Your tags: Add your first tag
 

Sell a Digital Version of This Book in the Kindle Store

If you are a publisher or author and hold the digital rights to a book, you can sell a digital version of it in our Kindle Store. Learn more

Customer Discussions

This product's forum
Discussion Replies Latest Post
No discussions yet

Ask questions, Share opinions, Gain insight
Start a new discussion
Topic:
First post:
Prompts for sign-in
 


Active discussions in related forums
Search Customer Discussions
Search all Amazon discussions
   
Related forums


Listmania!


Create a Listmania! list

So You'd Like to...


Create a guide


Look for Similar Items by Category


Look for Similar Items by Subject